UPDATED Apr 22, 2024
Companies with a Value score of at least 3, ordered by Value score
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CVS | US$65.50 | 0% | -1.0% | US$87.9b | US$83.18 | PE10.5x | E7.1% | 3.8% | ||
XRAY | US$28.53 | -1.5% | -24.4% | US$6.3b | US$34.26 | PS1.6x | E40.1% | 2.1% | ||
VEEV | US$184.55 | -4.8% | 8.5% | US$32.0b | US$224.18 | PE61.1x | E16.6% | n/a | ||
MDT | US$75.28 | -0.9% | -6.7% | US$105.5b | US$88.53 | PE25.5x | E10.3% | 3.4% | ||
ORP2 | €11.20 | 1.6% | -99.7% | €2.0b | €10,030.70 | PE-0.5x | E99.2% | 0% | ||
RMD | US$168.85 | -4.3% | -18.9% | US$26.3b | US$192.91 | PE29.8x | E13.5% | 1.1% | ||
PHIA | €18.97 | -1.5% | 0.1% | €17.3b | €20.21 | PB1.4x | E66.3% | n/a | ||
BIM | €103.30 | -2.7% | 6.3% | €11.8b | €114.66 | PE32.9x | E14.0% | 0.9% | ||
ABC | US$222.60 | 0.5% | 46.0% | US$47.7b | US$237.86 | PE25.3x | E7.7% | 0.9% | ||
FME | €38.97 | 10.2% | -8.0% | €11.4b | €39.00 | PE22.9x | E21.9% | 3.1% | ||
CIGN | US$332.70 | 0.8% | 43.7% | US$100.0b | US$359.32 | PE19.4x | E9.6% | 1.6% | ||
HSIC | US$67.32 | 1.1% | -13.2% | US$9.3b | US$75.35 | PE22.3x | E18.4% | n/a | ||
SHL | €51.58 | -3.5% | -10.8% | €57.4b | €60.47 | PE37.8x | E19.5% | 1.8% | ||
HOLX | US$71.00 | -1.4% | -8.6% | US$17.9b | US$78.50 | PE34.7x | E13.0% | n/a | ||
AFX | €98.70 | -4.8% | -20.8% | €8.8b | €108.78 | PE31.9x | E11.4% | 1.1% | ||
DEMA | kr.42.80 | 0.6% | 11.7% | kr.69.6b | kr.44.72 | PE27.3x | E12.5% | n/a | ||
ZBH | US$113.45 | -1.9% | -10.2% | US$24.8b | US$128.82 | PE24.2x | E8.5% | 0.8% | ||
ELV | US$500.40 | 5.7% | 19.7% | US$123.5b | US$559.73 | PE19.8x | E12.6% | 1.2% | ||
RHK | €11.70 | 3.5% | -12.0% | €789.9m | n/a | PE20.4x | n/a | 1.3% |